Education
About Us
Working with TipRanks
Follow Us
Kissei Pharmaceutical Co (JP:4547)
:4547
4547 Stock Chart & Stats
¥4170.00
-¥35.00(-0.84%)
At close: 4:00 PM EST
¥4170.00
-¥35.00(-0.84%)
Day’s Range― - ―
52-Week Range¥3,445.00 - ¥4,590.00
Previous CloseN/A
Volume139.00K
Average Volume (3M)60.08K
Market Cap
¥164.20B
Enterprise Value¥119.06B
Total Cash (Recent Filing)¥48.75B
Total Debt (Recent Filing)¥1.28B
Price to Earnings (P/E)11.7
Beta0.47
Next Earnings
Feb 03, 2026EPS Estimate
-115.29Last Dividend Ex-Date
Sep 29, 2025Dividend Yield2.86%
Share Statistics
EPS (TTM)78.93
Shares Outstanding46,541,985
10 Day Avg. Volume75,230
30 Day Avg. Volume60,080
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)0.80
Price to Sales (P/S)1.90
P/FCF Ratio83.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kissei Pharmaceutical Co News
4547 FAQ
What was Kissei Pharmaceutical Co’s price range in the past 12 months?
Kissei Pharmaceutical Co lowest stock price was ¥3445.00 and its highest was ¥4590.00 in the past 12 months.
What is Kissei Pharmaceutical Co’s market cap?
Kissei Pharmaceutical Co’s market cap is ¥164.20B.
When is Kissei Pharmaceutical Co’s upcoming earnings report date?
Kissei Pharmaceutical Co’s upcoming earnings report date is Feb 03, 2026 which is in 85 days.
How were Kissei Pharmaceutical Co’s earnings last quarter?
Kissei Pharmaceutical Co released its earnings results on Nov 04, 2025. The company reported ¥78.93 earnings per share for the quarter, beating the consensus estimate of ¥73.585 by ¥5.345.
Is Kissei Pharmaceutical Co overvalued?
According to Wall Street analysts Kissei Pharmaceutical Co’s price is currently Overvalued.
Does Kissei Pharmaceutical Co pay dividends?
Kissei Pharmaceutical Co pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 2.86%. See more information on Kissei Pharmaceutical Co dividends here
What is Kissei Pharmaceutical Co’s EPS estimate?
Kissei Pharmaceutical Co’s EPS estimate is -115.29.
How many shares outstanding does Kissei Pharmaceutical Co have?
Kissei Pharmaceutical Co has 46,541,985 shares outstanding.
What happened to Kissei Pharmaceutical Co’s price movement after its last earnings report?
Kissei Pharmaceutical Co reported an EPS of ¥78.93 in its last earnings report, beating expectations of ¥73.585. Following the earnings report the stock price went down -0.621%.
Which hedge fund is a major shareholder of Kissei Pharmaceutical Co?
Currently, no hedge funds are holding shares in JP:4547
Company Description
Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company primarily engaged in the research, development, manufacturing, and marketing of prescription drugs. The company operates in various sectors, including diabetes management, urology, and central nervous system disorders, and focuses on innovative therapies that address unmet medical needs. Kissei's core products include medications for diabetes such as the GLP-1 receptor agonist and various other treatments that enhance the quality of life for patients with chronic conditions.
Technical Analysis
Kaken Pharmaceutical Co
―
Torii Pharmaceutical Co
―
Towa Pharmaceutical Co
―
Mochida Pharmaceutical Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Options Prices
Currently, No data available
---